health pharma news today obesity drugs glp-1 today october 2025 Outlook for obesity in 2025: more Could weight-loss drugs eat the

From needles to pills: oral GLP-1 therapy enters the obesity arena

People who took Zepbound, which is a GLP-1 RA drug, and were diagnosed with NAION can speak to an attorney about whether or not they qualify to join this litigation

Sammen med specialrunder og daglige missioner bliver det lettere at kombinere strategi og sjov

Patients experience abnormal stomach movement that lasts at least three months

Endometrial cancer is rising fastest in younger women, it is tightly linked to obesity, and we have almost nothing to offer for prevention, Kamat explained

Always inform your healthcare provider about all supplements you are taking